← back to search

Xiangguo Qiu

National Institute of Allergy and Infectious Diseases · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Virology, Ebola virus, Biology, Monoclonal antibody, Ebolavirus, and Antibody.
h-index
citations
769
works
8
NIH funding
primary concept
email

Recent publications

Biological activity-based modeling identifies antiviral leads against SARS-CoV-2
Nature Biotechnology 2021cited by 52position: middledoi
Massive-scale biological activity-based modeling identifies novel antiviral leads against SARS-CoV-2
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 15position: middledoi
Peste des Petits Ruminants Virus-Like Particles Induce a Potent Humoral and Cellular Immune Response in Goats
Viruses 2019cited by 14position: lastdoi
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Cell Host & Microbe 2018cited by 240position: middledoi
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Cell 2018cited by 227position: middledoi
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
Cell Discovery 2018cited by 191position: middledoi
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
Cell Reports 2018cited by 50position: middledoi
HBV antigen and DNA loss from mouse serum is associated with novel vaccine-induced HBV surface antigen-specific cell-mediated immunity and cytokine production
Antiviral Research 2018cited by 5position: middledoi
Clinical Evaluation of Ebola Virus Disease Therapeutics
Trends in Molecular Medicine 2017cited by 21position: lastdoi
Adeno-Associated Virus Serotype 9-Expressed ZMapp in Mice Confers Protection Against Systemic and Airway-Acquired Ebola Virus Infection
The Journal of Infectious Diseases 2016cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christopher P. Austin · Jersey Shore University Medical Center2 papers (2020–2021)Anton Simeonov · National Human Genome Research Institute2 papers (2020–2021)Hu Zhu · The University of Texas MD Anderson Cancer Center2 papers (2020–2021) · 2 papers (2020–2021)Donald C. Lo · Center for Translational Molecular Medicine2 papers (2020–2021)Shihua He · University of Manitoba2 papers (2020–2021)Catherine Z. Chen · National Human Genome Research Institute2 papers (2020–2021) · 2 papers (2020–2021)Ruili Huang · Guangzhou University of Chinese Medicine2 papers (2020–2021) · 2 papers (2020–2021)Emily M. Lee · Florida State University2 papers (2020–2021)Wei Zheng · University of Alabama at Birmingham2 papers (2020–2021)Hengli Tang · Florida State University2 papers (2020–2021)Wenwei Huang · Zhejiang Normal University2 papers (2020–2021)Maria P. Limberis · Gene Therapy Laboratory1 papers (2016–2016)Entao Li · South China Agricultural University1 papers (2019–2019)James M. Wilson · Brigham and Women's Hospital1 papers (2016–2016)Gary Kobinger · Quebec - Clinical Research Organization in Cancer1 papers (2017–2017)Wenjie Tan · Hebei Medical University1 papers (2018–2018)Zachary Schiffman · University of Manitoba1 papers (2019–2019)